STOK
Biogen Shares up About 1%
时间:2025-02-18 22:41:25 市场: 美股 综合
Stoke Therapeutics Shares up 3.5% After Co Enters Partnership With Biogen to Develop, Sell Epilepsy Drug
时间:2025-02-18 22:41:25 市场: 美股 综合
Stoke Therapeutics, Inc. : H.c. Wainwright Raises Target Price to $47 From $35
时间:2025-02-18 22:30:17 市场: 美股 综合
Biogen and Stoke Therapeutics Enter Into Collaboration to Develop and Commercialize Zorevunersen for the Treatment of Dravet Syndrome, a Rare Genetic Epilepsy Associated With Refractory Seizures and Neurodevelopmental Impairments
时间:2025-02-18 21:00:01 市场: 美股 综合
Stoke Therapeutics Q3 Basic EPS USD -0.47
时间:2024-11-05 20:00:00 市场: 美股 综合